Christine Granfield - Sep 1, 2022 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
VP, Head of Reg Affairs/Qual
Signature
/s/ Douglas E. Onsi, as attorney-in-fact for Christine Granfield
Stock symbol
LPTX
Transactions as of
Sep 1, 2022
Transactions value $
$0
Form type
4
Date filed
9/2/2022, 09:29 PM
Previous filing
Feb 2, 2022
Next filing
Apr 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPTX Employee Stock Option (Right to Buy) Award $0 +200K $0.00 200K Sep 1, 2022 Common Stock 200K $1.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option was granted pursuant to Leap's 2022 Equity Incentive Plan and shall vest and become exercisable in a series of 36 equal monthly installments until the Option is fully vested, with the first such monthly installment vesting on the one month anniversary of September 1, 2022, the Vesting Start Date.